BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 1549953)

  • 41. Sodium fluoride lacks mitogenic activity for fetal human bone cells in vitro.
    Kopp JB; Robey PG
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S137-41. PubMed ID: 2339623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of caffeine on parameters of osteoblast growth and differentiation of a mineralized extracellular matrix in vitro.
    Tassinari MS; Gerstenfeld LC; Stein GS; Lian JB
    J Bone Miner Res; 1991 Oct; 6(10):1029-36. PubMed ID: 1796750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy.
    Marie PJ; Lomri A; de Vernejoul MC; Morieux C; Graulet AM; Guéris J; Llach F
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1166-73. PubMed ID: 2555383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo.
    Lau KH; Nakade O; Barr B; Taylor AK; Houchin K; Baylink DJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2347-53. PubMed ID: 7629228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis.
    Parfitt AM; Villanueva AR; Foldes J; Rao DS
    J Bone Miner Res; 1995 Mar; 10(3):466-73. PubMed ID: 7785469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Tinospora cordifolia (Menispermaceae) on the proliferation, osteogenic differentiation and mineralization of osteoblast model systems in vitro.
    Abiramasundari G; Sumalatha KR; Sreepriya M
    J Ethnopharmacol; 2012 May; 141(1):474-80. PubMed ID: 22449439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.
    Hauge EM; Qvesel D; Eriksen EF; Mosekilde L; Melsen F
    J Bone Miner Res; 2001 Sep; 16(9):1575-82. PubMed ID: 11547826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age.
    Fedarko NS; D'Avis P; Frazier CR; Burrill MJ; Fergusson V; Tayback M; Sponseller PD; Shapiro JR
    J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteoblastic proliferation in bone biopsies from patients with end-stage chronic renal failure.
    Serrano S; Mariñoso ML; Torres A; Lorenzo V; Keysers U; Lloreta J; Nacher M; Garcia C; Ballester J; Diez A; Aubia J
    J Bone Miner Res; 1997 Feb; 12(2):191-9. PubMed ID: 9041050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone turnover in spinal osteoporosis.
    Pødenphant J; Johansen JS; Thomsen K; Riis BJ; Leth A; Christiansen C
    J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation.
    Marie PJ; Hott M; Launay JM; Graulet AM; Gueris J
    J Clin Endocrinol Metab; 1993 Sep; 77(3):824-30. PubMed ID: 8370705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro.
    Bian Q; Liu SF; Huang JH; Yang Z; Tang DZ; Zhou Q; Ning Y; Zhao YJ; Lu S; Shen ZY; Wang YJ
    Menopause; 2012 Feb; 19(2):225-33. PubMed ID: 22011754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats.
    Machwate M; Zerath E; Holy X; Pastoureau P; Marie PJ
    Endocrinology; 1994 Mar; 134(3):1031-8. PubMed ID: 8119139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of periodic tension on osteoblast-like cells for cell differentiation and alkaline phosphatase activity].
    Miyajima K
    Nihon Kyosei Shika Gakkai Zasshi; 1990 Jun; 49(3):226-36. PubMed ID: 2133880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of fluoride on bone and implant histomorphometry in growing rats.
    Turner RT; Francis R; Brown D; Garand J; Hannon KS; Bell NH
    J Bone Miner Res; 1989 Aug; 4(4):477-84. PubMed ID: 2816497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro.
    Kasperk CH; Wakley GK; Hierl T; Ziegler R
    J Bone Miner Res; 1997 Mar; 12(3):464-71. PubMed ID: 9076590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.
    Farley JR; Hall SL; Tarbaux NM
    Calcif Tissue Int; 1989 Oct; 45(4):214-21. PubMed ID: 2509008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanism of action of fluoride on bone cells.
    Lau KH; Baylink DJ
    J Bone Miner Res; 1998 Nov; 13(11):1660-7. PubMed ID: 9797473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro.
    Nakade O; Baylink DJ; Lau KH
    J Dent Res; 1995 Jan; 74(1):331-7. PubMed ID: 7876426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation.
    Kawelke N; Bentmann A; Hackl N; Hager HD; Feick P; Geursen A; Singer MV; Nakchbandi IA
    J Bone Miner Res; 2008 Aug; 23(8):1278-86. PubMed ID: 18348696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.